Carmat
Manufacturing · France · 51-200 Employees
View Company Info for Free
Overview
Headquarters
36 Ave De L'europe, Velizy-Villacoublay,...Phone Number
+33 139456450Website
www.carmatsa.comRevenue
$7.5 MillionStock Symbol
ALCARIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1
About Carmat
Carmat is a medical device manufacturing company founded in 2008 that develops innovative solutions for end-stage heart failure. The company focuses on creating advanced artificial heart technology to address chronic and acute heart failure, a major public health issue and leading cause of death worldwide. With operations across multiple continents including Europe, North America, and Asia, Carmat combines medical expertise with engineering innovation to produce life-saving cardiac devices. The company went public in 2019 and continues to advance its mission of providing viable treatment options for patients suffering from severe heart conditions.Explore more
Carmat Org Chart
Show More
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Carmat your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Carmat recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Carmat
Carmat, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Carmat has new funding data
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Carmat launches new products
Check out if Carmat is spiking on competitors!
Click to see if Carmat had a recent Job posting/layoffs
Check if Carmat has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Carmat as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
Carmat is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Carmat is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Carmat.
Carmat financials insights
Gather financial insights about Carmat, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Other Financing Round
$18.6M
2023
Other Financing Round
$7.4M
Carmat Tech Stack
A closer look at the technologies used by Carmat
See more technologies
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Person-Based
Person-Based
Person-Based
Person-Based
Carmat News & Media
CARMAT Announces Being in a Critical Financial Situation and at Risk of Insolvency as of ...
Regulatory News: CARMAT (FR0010907956, ALCAR), designer and developer of the world’s most advanced total artificial heart, aiming to provide a therapeutic al...CARMAT Delivers Q1 2025 Results in Line With Its Objectives
PARIS--(BUSINESS WIRE)--Regulatory News: CARMAT (Paris:ALCAR): Videoconference in English and French this evening. To join, please register by clicking on one of the following links: Videoconference in French at 6:00 pm CEST - Videoconference in English at 8:00 pm CEST CARMAT (FR0010907956, ALCAR), designer and developer of the world’s most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from advanced biventricular heart failure (the “Company” oCARMAT announces the implementation of a flexible equity financing line with IRIS Capital Investment
PARIS--(BUSINESS WIRE)--Regulatory News: CARMAT (FR0010907956, ALCAR), designer and developer of the world’s most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from advanced biventricular heart failure (the “Company” or “CARMAT”), announces the implementation of a flexible equity financing line with IRIS Capital Investment (“IRIS”), for a maximum of 9,000,000 shares (i.e., approximately 15% of its current share capital), over a 24-month periodCARMAT Raises a Total of €9.7 Million | Business Wire
CARMAT Raises a Total of €9.7 Million
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Carmat
Sign Up For FreeTo access detailed company insights
Carmat is a medical device manufacturing company founded in 2008 that develops innovative solutions for end-stage heart failure. The company focuses on creating advanced artificial heart technology to address chronic and acute heart failure, a major public health issue and leading cause of death worldwide. With operations across multiple continents... Read More
